Sino Biopharmaceutical Limited. [Photo/Sino Biopharm website] Sino Biopharmaceutical Limited, or Sino Biopharm, a leading innovative research and development-driven pharmaceutical conglomerate in China, announced on Thursday in its annual result report that revenues from innovative drugs reached 9.89 billion yuan ($1.37 billion) in the 2023 fiscal year, up 13.3 percent year-on-year. Despite a challenging environment last year, … Continue reading Sino Biopharm shows stable growth in 2023